Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Matthew Beasey"'
Autor:
Pavan Annamaraju, Swathi Gopishetty, Naga Goparaju, Matthew Beasey, Vamsi Kota, Achuta K. Guddati
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 2, Pp 583-587 (2020)
Enasidenib is an FDA-approved isocitrate dehydrogenase 2 (IDH2) inhibitor, which is used in the treatment of acute myeloid leukemia (AML). We present a case of AML with an IDH2 mutation treated with a regimen of enasidenib and 5-azacitidine, where th
Externí odkaz:
https://doaj.org/article/a98464ff85ad428ea0c90ef86216f711
Autor:
Swathi Gopishetty, Pavan Annamaraju, Achuta Kumar Guddati, Matthew Beasey, Naga Goparaju, Vamsi Kota
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 2, Pp 583-587 (2020)
Case Reports in Oncology
Case Reports in Oncology
Enasidenib is an FDA-approved isocitrate dehydrogenase 2 (IDH2) inhibitor, which is used in the treatment of acute myeloid leukemia (AML). We present a case of AML with an IDH2 mutation treated with a regimen of enasidenib and 5-azacitidine, where th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e89de57bc1e14759b157f5c4ba1bb388
https://www.karger.com/Article/FullText/507613
https://www.karger.com/Article/FullText/507613
Publikováno v:
The Journal of Hand Surgery. 17:1055-1057
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::967c6bbea7a54ea69db97927c10253bc
https://doi.org/10.1016/s0363-5023(09)91060-7
https://doi.org/10.1016/s0363-5023(09)91060-7